Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Multicenter Study of Pegylated Interferon α-2a Monotherapy for Hepatitis C Virus-Infected Patients on Hemodialysis: REACH Study.

Kikuchi K, Akiba T, Nitta K, Masakane I, Ando R, Izumi N, Atsukawa M, Yamazaki C, Kato F, Hotta N, Tominaga Y, Orito E, Hora K, Nagasawa M, Kasahara H, Kawaguchi M, Kimura H, Ikebe N, Kawanishi H, Moriishi M, Shigemoto K, Harada T, Hirakata H, Watanabe H, Nosaki T, Tsubouchi H, Imawari M, Akizawa T.

Ther Apher Dial. 2014 Sep 4. doi: 10.1111/1744-9987.12189. [Epub ahead of print]

PMID:
25196061
[PubMed - as supplied by publisher]
2.

Distinct molecular features of different macroscopic subtypes of colorectal neoplasms.

Konda K, Konishi K, Yamochi T, Ito YM, Nozawa H, Tojo M, Shinmura K, Kogo M, Katagiri A, Kubota Y, Muramoto T, Yano Y, Kobayashi Y, Kihara T, Tagawa T, Makino R, Takimoto M, Imawari M, Yoshida H.

PLoS One. 2014 Aug 5;9(8):e103822. doi: 10.1371/journal.pone.0103822. eCollection 2014.

PMID:
25093594
[PubMed - in process]
3.

Contribution of diuretic therapy with human serum albumin to the management of ascites in patients with advanced liver cirrhosis: A prospective cohort study.

Nakamura T, Sata M, Hiroishi K, Masaki N, Moriwaki H, Murawaki Y, Yatsuhashi H, Fujiyama S, Imawari M.

Mol Clin Oncol. 2014 May;2(3):349-355. Epub 2014 Jan 16.

PMID:
24772299
[PubMed]
4.

Restoration of natural killer cell activity by pegylated interferon-alpha/ribavirin therapy in chronic hepatitis C patient.

Nakamura I, Asano T, Asabe S, Ando M, Sano T, Miyata Y, Taira J, Sugimoto K, Imai Y, Moriyasu F, Imawari M.

Hepatol Res. 2014 Mar 10. doi: 10.1111/hepr.12322. [Epub ahead of print]

PMID:
24606027
[PubMed - as supplied by publisher]
5.

World gastroenterology organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013.

Umar M, Khan AG, Abbas Z, Arora S, Asifabbas N, Elewaut A, Esmat G, Foster G, Fried M, Goh KL, Hamama TB, Imawari M, Isakov V, Krabshuis J, LaBrecque D, Lemair A, Malfertheiner P, Ryder S, Schiedermaier P, Stimac D, Tandon R, Villamil F, Zapata R, Ferenci P.

J Clin Gastroenterol. 2014 Mar;48(3):204-17. doi: 10.1097/MCG.0000000000000050. No abstract available.

PMID:
24504078
[PubMed - in process]
6.

In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation.

Nakagawa H, Mizukoshi E, Iida N, Terashima T, Kitahara M, Marukawa Y, Kitamura K, Nakamoto Y, Hiroishi K, Imawari M, Kaneko S.

Cancer Immunol Immunother. 2014 Apr;63(4):347-56. doi: 10.1007/s00262-013-1514-7. Epub 2014 Jan 3.

PMID:
24384836
[PubMed - indexed for MEDLINE]
7.

Scoring system for predicting recurrence after chemoradiotherapy including 5-fluorouracil and platinum for patients with esophageal cancer.

Kogo M, Suzuki A, Sunaga T, Kaneko K, Imawari M, Kiuchi Y.

Hepatogastroenterology. 2013 Nov-Dec;60(128):1979-84.

PMID:
24088316
[PubMed - indexed for MEDLINE]
8.

Hepatitis C patients on maintenance hemodialysis show complex immune disturbances in the peripheral blood.

Shiina M, Kobayashi K, Hiroishi K, Imawari M.

Viral Immunol. 2013 Oct;26(5):351-6. doi: 10.1089/vim.2013.0026. Epub 2013 Sep 10.

PMID:
24020832
[PubMed - indexed for MEDLINE]
9.

Open-labeled randomized controlled trial to compare diuretic therapy with recombinant human serum albumin and diuretic therapy for therapeutic treatment of ascites in patients with advanced liver cirrhosis: An exploratory trial.

Nakamura T, Sata M, Suzuki K, Moriwaki H, Fukui H, Fujiyama S, Imawari M.

Hepatol Res. 2014 May;44(5):502-14. doi: 10.1111/hepr.12142. Epub 2013 May 26.

PMID:
23607459
[PubMed]
10.

Clinical efficacy of combination therapy with ME3738 and pegylated interferon-alpha-2a in patients with hepatitis C virus genotype 1.

Saibara T, Enomoto N, Kaneko S, Chayama K, Sata M, Imawari M, Onishi S, Okita K.

Hepatol Res. 2013 Apr 19. doi: 10.1111/hepr.12139. [Epub ahead of print]

PMID:
23607362
[PubMed - as supplied by publisher]
11.

Long-term enteral immunonutrition containing lactoferrin in tube-fed bedridden patients: immunological and nutritional status.

Takeuchi Y, Yamamura T, Takahashi S, Katayose K, Kohga S, Takase M, Imawari M.

J Am Coll Nutr. 2012 Jun;31(3):206-13.

PMID:
23204157
[PubMed - indexed for MEDLINE]
12.

Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid.

Honda A, Ikegami T, Nakamuta M, Miyazaki T, Iwamoto J, Hirayama T, Saito Y, Takikawa H, Imawari M, Matsuzaki Y.

Hepatology. 2013 May;57(5):1931-41. doi: 10.1002/hep.26018. Epub 2013 Apr 5.

PMID:
22911624
[PubMed - indexed for MEDLINE]
13.

Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.

Miyashita M, Ito T, Sakaki M, Kajiwara A, Nozawa H, Hiroishi K, Kobayashi M, Kumada H, Imawari M.

J Viral Hepat. 2012 Sep;19(9):608-14. doi: 10.1111/j.1365-2893.2011.01580.x. Epub 2012 Jan 28.

PMID:
22863264
[PubMed - indexed for MEDLINE]
14.

2011 Japanese Society for Dialysis Therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients.

Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T.

Ther Apher Dial. 2012 Aug;16(4):289-310. doi: 10.1111/j.1744-9987.2012.01078.x. Epub 2012 Jun 11. No abstract available.

PMID:
22817117
[PubMed - indexed for MEDLINE]
15.

Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.

Omori R, Eguchi J, Hiroishi K, Ishii S, Hiraide A, Sakaki M, Doi H, Kajiwara A, Ito T, Kogo M, Imawari M.

Cancer Gene Ther. 2012 Sep;19(9):637-43. doi: 10.1038/cgt.2012.42. Epub 2012 Jul 13.

PMID:
22790963
[PubMed - indexed for MEDLINE]
16.

25-Hydroxyvitamin D3 suppresses hepatitis C virus production.

Matsumura T, Kato T, Sugiyama N, Tasaka-Fujita M, Murayama A, Masaki T, Wakita T, Imawari M.

Hepatology. 2012 Oct;56(4):1231-9. doi: 10.1002/hep.25763.

PMID:
22487892
[PubMed - indexed for MEDLINE]
17.

Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses.

Kajiwara A, Doi H, Eguchi J, Ishii S, Hiraide-Sasagawa A, Sakaki M, Omori R, Hiroishi K, Imawari M.

Oncol Rep. 2012 Jun;27(6):1765-71. doi: 10.3892/or.2012.1723. Epub 2012 Mar 15.

PMID:
22426807
[PubMed - indexed for MEDLINE]
18.

Lymphotropic hepatitis C virus has an interferon-resistant phenotype.

Inokuchi M, Ito T, Nozawa H, Miyashita M, Morikawa K, Uchikoshi M, Shimozuma Y, Arai J, Shimazaki T, Hiroishi K, Imawari M.

J Viral Hepat. 2012 Apr;19(4):254-62. doi: 10.1111/j.1365-2893.2011.01541.x. Epub 2011 Oct 17.

PMID:
22404723
[PubMed - indexed for MEDLINE]
19.

Factors involved in resistance to early treatment of acute cholangitis patients.

Yoneyama K, Saito H, Kurihara T, Kogo M, Kitamura K, Iwata T, Imawari M, Kiuchi Y.

Hepatogastroenterology. 2012 Sep;59(118):1722-6. doi: 10.5754/hge11782.

PMID:
22193432
[PubMed - indexed for MEDLINE]
20.

DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis.

Konishi K, Watanabe Y, Shen L, Guo Y, Castoro RJ, Kondo K, Chung W, Ahmed S, Jelinek J, Boumber YA, Estecio MR, Maegawa S, Kondo Y, Itoh F, Imawari M, Hamilton SR, Issa JP.

PLoS One. 2011;6(11):e27889. doi: 10.1371/journal.pone.0027889. Epub 2011 Nov 21.

PMID:
22132162
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk